Recap: Pacira BioSciences Q1 Earnings - Pacira BioSciences (NASDAQ:PCRX)

Pacira BioSciences PCRX reported its Q1 earnings results on Wednesday, May 3, 2023 at 08:00 AM.

Here's what investors need to know about the announcement.

Pacira BioSciences missed estimated earnings by 14.52%, reporting an EPS of $0.53 versus an estimate of $0.62.

Revenue was up $2.35 million from the same period last year.

Last quarter the company missed on EPS by $0.03 which was followed by a 1.9% increase in the share price the next day.

Here's a look at Pacira BioSciences's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0.83	0.76	0.88	0.83
EPS Actual	0.80	0.64	0.51	0.64
Revenue Estimate	173.50M	168.89M	171.43M	159.49M
Revenue Actual	171.96M	167.47M	169.41M	157.99M

To track all earnings releases for Pacira BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.